NUEVA YORK, USA. Ómicron tiene una nueva mutación en comparación con otras variantes. Sin embargo, esta mutación está presente en el virus del resfriado común, el virus de inmunodeficiencia humana y el genoma humano. ¿Es ómicron el resultado de una recombinación entre el SARS-CoV-2 y estos materiales genéticos? ¿Virus “humanizado”? La […]
Read More
While the world waits on data regarding omicron, a coronavirus variant that has spread rapidly around the world, epidemiologists and health care experts again point to basic public health practices that can significantly reduce the spread of disease. While concerns have arisen about whether the existing COVID-19 vaccines will be […]
Read More
Most of the 43 cases of the COVID-19 Omicron variant found in the United States were mild and occurred among vaccinated people, but boosters are effective against it, according to a report the CDC released Friday. Of the 43 people with cases, more than half were 19 to 39 years […]
Read More
A study led by researchers from the LKS Faculty of Medicine at The University of Hong Kong (HKUMed) provides the first information on how the novel Variant of Concern (VOC) of SARS-CoV-2, the Omicron SARS-CoV-2 infect human respiratory tract. The researchers found that Omicron SARS-CoV-2 infects and multiplies 70 times […]
Read More
There’s been great concern about the new Omicron variant of SARS-CoV-2, the coronavirus that causes COVID-19. A major reason is Omicron has accumulated over 50 mutations, including about 30 in the spike protein, the part of the coronavirus that mRNA vaccines teach our immune systems to attack. All of these genetic […]
Read More
As the omicron variant sparks worldwide fears of renewed COVID-19 outbreaks, Americans’ worries about infection are again on the rise, but fewer say they are regularly wearing masks or isolating compared with the beginning of the year. A new poll conducted by The Associated Press and NORC Center for Public […]
Read More
Researchers at Mayo Clinic and around the world continue to monitor the omicron variant and study how it behaves. Dr. Gregory Poland, head of Mayo Clinic’s Vaccine Research Group, who has decades of experience in the field of infectious diseases, offers some insight into what the emergence of omicron tells us about […]
Read More
Ómicron y COVID-19 en Iberoamérica El 8 de diciembre el director de la Organización Mundial de la Salud (OMS), Tedros Adhanom Ghebreyesus, Ph. D., informó que ómicron se ha identificado ya en 57 países en el mundo y se espera que la variante se identifique en más. En sus apalbras de apertura […]
Read More
Pfizer y BioNTech anunciaron hoy, miércoles, que los resultados de un estudio de laboratorio inicial demostraron que los anticuerpos inducidos por su vacuna contra el COVID-19 neutralizan los efectos de la variante ómicron después de tres dosis. Los sueros obtenidos de los vacunados un mes después de recibir la vacuna de refuerzo (tercera dosis de la vacuna BNT162b2) neutralizaron la variante ómicron a niveles […]
Read More
New research helps bolster the argument for getting COVID-19 booster shots now, even though the formulations are not specifically targeted to the latest Omicron and Delta variants, researchers suggest in a paper published today. Dr Otto Yang Senior author Otto Yang, MD, professor in the division of infectious diseases and […]
Read More